Lyra Therapeutics, Inc. (LYRA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Cash from Operations | -6.07M | -7.36M | -6.59M | -8.84M | -11.35M | -16.22M | -19.98M | -22.45M | -19.06M | -14.11M | -14.28M | -15.85M | -12.16M | -10.85M | -8.47M | -11.9M | -11.3M | -10.31M | 3.38M | -7.59M |
| Operating CF Margin % | -86657.14% | -29444% | -3601.09% | -4831.69% | -5431.58% | -8319.49% | -3341.3% | -4220.86% | -13053.42% | -2594.49% | -3118.34% | -3865.85% | -110581.82% | -3021.17% | -1613.33% | -2543.8% | -4168.63% | -73671.43% | - | - |
| Operating CF Growth % | 46.56% | 54.63% | 67.02% | 60.62% | 40.43% | -14.94% | -39.9% | -41.67% | -56.68% | -30.13% | -68.62% | -33.14% | -7.67% | -5.16% | -350.52% | -56.85% | -92.52% | -172.86% | 145.21% | -88.95% |
| Net Income | -6.95M | -5.98M | -7.44M | -8.55M | -10.98M | -11.87M | -48.13M | -22.45M | -15.16M | -15.65M | -15.62M | -16.25M | -14.23M | -14.77M | -14.48M | -11.91M | -13.62M | -11.05M | -11.04M | -7.8M |
| Depreciation & Amortization | 100K | 100K | 127K | 128K | 151K | 39K | 145K | 136K | 85K | -68K | 0 | 284K | 222K | 279K | 286K | 280K | 278K | 400K | 300K | 70K |
| Stock-Based Compensation | 562K | 0 | 914K | 825K | 1.94M | 1.49M | 1.12M | 2.16M | 1.48M | 1.44M | 0 | 1.61M | 1.76M | 1.74M | 1.11M | 844K | 782K | 0 | 0 | 599K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.19M | 0 | 0 | 0 | 0 | 0 | -2.67M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 223K | 38K | -8K | 0 | -267K | -401K | 24.18M | -933K | 4.1M | -1.06M | 2.3M | -726K | 824K | 0 | 2.67M | 0 | 0 | 683K | 659K | 0 |
| Working Capital Changes | 0 | -1.51M | -186K | -1.25M | -2.2M | -5.48M | 2.7M | -1.37M | -4.38M | 1.22M | -961K | -763K | -732K | 1.9M | 4.62M | -1.12M | 1.26M | -342K | 13.46M | -457K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5M | -5M | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5M | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 103K | -120K | -45K | -454K | -1.11M | -2.59M | 2.38M | -560K | -3.54M | 796K | -106K | 3.29M | -2.24M | 1.47M | -976K | -663K | 1.18M | 424K | 291K | 452K |
| Cash from Investing | -96K | 0 | -2K | 0 | 28.13M | 8.14M | 36.18M | 7.86M | -2.36M | -14.98M | -561K | 5.32M | -64.87M | -29K | -14K | -93K | -1.08M | -517K | -625K | -1.16M |
| Capital Expenditures | -96K | 0 | -20K | 0 | 58K | -51K | -196K | -2.15M | -787K | -144K | -71K | -45K | -28K | -29K | -14K | -93K | -1.08M | -517K | -625K | -1.16M |
| CapEx % of Revenue | 1371.43% | - | 10.93% | - | 27.75% | 26.15% | 32.78% | 403.95% | 539.04% | 26.47% | 15.5% | 10.98% | 254.55% | 8.08% | 2.67% | 19.87% | 399.63% | 3692.86% | - | - |
| Acquisitions | 0 | 0 | 18K | 0 | 0 | 0 | 0 | 0 | 0 | 14.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | -368K | 4.64M | 0 | -1K | -23K | -89K | 8.64M | 18.92M | -418K | 47.19M | 4K | 0 | -236K | 96.49M | 6K | -4K | -84K | 185K | 262K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 5M | 0 | -1K | 0 | 9K | 8.81M | 19.24M | 2K | 50.1M | 0 | 100.5M | 0 | 0 | 8K | 0 | 11K | 331K | 262K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -368K | -358K | 0 | 0 | -23K | -98K | -166K | -322K | -420K | -2.91M | 4K | -100.5M | -236K | 96.49M | -2K | -4K | -95K | -146K | 0 |
| Net Change in Cash | -6.16M | -7.73M | -1.95M | -8.84M | 16.78M | -8.11M | 16.11M | -5.95M | -2.5M | -29.51M | 32.65M | -10.53M | -77.34M | -11.11M | 88M | -11.99M | -12.38M | -10.91M | 2.94M | -8.49M |
| Free Cash Flow | -6.16M | -7.36M | -6.61M | -8.84M | -11.29M | -16.27M | -20.18M | -24.6M | -19.84M | -14.26M | -14.35M | -15.89M | -12.19M | -10.88M | -8.48M | -12M | -12.38M | -10.83M | 2.76M | -8.75M |
| FCF Margin % | -88028.57% | -29444% | -3612.02% | -4831.69% | -5403.83% | -8345.64% | -3374.08% | -4624.81% | -13592.47% | -2620.96% | -3133.84% | -3876.83% | -110836.36% | -3029.25% | -1616% | -2563.68% | -4568.27% | -77364.29% | - | - |
| FCF Growth % | 45.44% | 54.77% | 67.24% | 64.06% | 43.09% | -14.14% | -40.58% | -54.79% | -62.77% | -31.11% | -69.18% | -32.48% | 1.52% | -0.41% | -407.84% | -37.12% | -77.64% | -147.91% | 136.48% | -117.39% |
| FCF per Share | -0.40 | -4.16 | -4.90 | -0.13 | -0.17 | -0.25 | -0.31 | -0.38 | -0.32 | -0.25 | -0.33 | -0.43 | -0.38 | -0.30 | -0.25 | -0.92 | -0.95 | -0.83 | 0.21 | -0.68 |
| FCF Conversion (FCF/Net Income) | 0.87x | 1.23x | 0.89x | 1.03x | 1.03x | 1.37x | 0.42x | 1.00x | 1.26x | 0.90x | 0.91x | 0.98x | 0.85x | 0.73x | 0.59x | 1.00x | 0.83x | 0.93x | -0.31x | 0.97x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |